…effective. Addressing Co-Infections and Real-World Treatment Needs HIV rarely exists in isolation. In 2025, Texas Biomed and the Southwest NPRC demonstrated that a promising tuberculosis therapy did not interfere with…

…effective against other mutating viruses, including SARS-CoV-2. The vaccine platform, which uses cytomegalovirus (CMV) as a vector, was originally developed to fight HIV and tuberculosis. It works by inducing an…

Researchers at Texas Biomedical Research Institute (Texas Biomed) have made significant progress in the fight against tuberculosis (TB) and HIV co-infection. The team, led by Professor Smriti Mehra, Ph.D., has…

…  Infectious Disease 2. A Deadly Relationship: Stopping the Progression of Tuberculosis in HIV Patients Researchers at the Southwest National Primate Research Center have discovered chronic immune activation in the…

…expertise needed to work with these animals to help us combat international health crises, including diseases such as Zika and Malaria, tuberculosis and most recently, COVID-19. In addition, the Centers…

Tuberculosis (TB) is a serious infectious disease that typically affects the lungs. Spread of TB typically occurs in the air via coughs or sneezes. T reatment often poses a challenge…

Tuberculosis (TB) is a serious disease that mostly affects the lungs, but can also cause damage to the kidneys, spine or brain. TB spreads from person to person through small…

Tuberculosis (TB) and HIV are two of the world’s deadliest infectious diseases, and they’re far worse when they occur together. Now, Southwest National Primate Research Center (SNPRC) researchers at Texas…

One primary objective of tuberculosis (TB) research is to discover how to treat people with the latent (or inactive) form of the disease so they don’t develop symptomatic TB. Now,…

Tuberculosis (TB) kills 1.6 million people every year and is one of the top 10 causes of death globally. And while it’s been kept under control in most places, more…

…refine the way it approaches vaccine development, noting a similar approach could possibly be feasible for other pathogens, including influenza, tuberculosis, malaria and COVID-19. As the search for a cure…

…outcome. For example, patients infected with HIV-1, a virus that causes AIDS, are more susceptible to tuberculosis infection. “A significant number of people entering Ebola Virus Treatment Units during the…

Tuberculosis is a major concern for HIV/AIDS patients, as a full one-third of all patients with the autoimmune disease die of complications from TB. But Professor Deepak Kaushal, PhD, of…

Young macaques form an important part of our work at the NPRCs, helping us discover new ways of treating deadly diseases like tuberculosis, HIV/AIDS, Zika and more. Two researchers at…

…for Tuberculosis Research within the Tulane National Primate Research Cente r (TNPRC) in Covington, La., and Professor in the Department of Microbiology and Immunology at Tulane University School of Medicine…

…with M. tuberculosis and all had to be humanely euthanized after 13 weeks. “Our study demonstrated that pre-existing SIV dramatically diminishes the ability to control M. tuberculosis co-infection from the…

Can a promising cancer drug also treat tuberculosis (TB), the world’s single deadliest infectious disease? Researchers at the Texas Biomedical Research Institute, host institution for the Southwest National Primate Research…

…Tuberculosis – TB kills approximately 2 million human beings each year. NPRC researchers have developed robust NHP models of the various presentations of the human TB syndrome, including those that…